Moloney Securities Asset Management, LLC Halozyme Therapeutics, Inc. Transaction History

Moloney Securities Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$31.97 - $41.06 $471,557 - $605,635	-14,750 Closed	0 $0
Q3 2021 Oct 27, 2021	SELL	$38.47 - $46.42 $173,115 - $208,890	-4,500 Reduced 23.38%	14,750 $600,000
Q4 2020 Feb 08, 2021	BUY	$25.81 - $43.62 $116,145 - $196,290	4,500 Added 30.51%	19,250 $822,000
Q3 2020 Oct 20, 2020	BUY	$25.74 - $29.63 $379,665 - $437,042	14,750 New	14,750 $388,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.